On March 14, 2016, I.M.A. Industria Macchine Automatiche S.p.A. (I.M.A.), Bologna, Italy (Milan Stock Exchange: IMA), announced that it signed an agreement to acquire Komax group's medtech business. Komax group is a leader in the market of machines for assembling medical products for self-medication, such as inhalers, syringes and insulin injection systems. Closing of the acquisition is subject to relevant antitrust approvals.

I.M.A. and Komax have agreed to a payment of CHF 28 million and a further payment of CHF 6 million by way of an earn-out and a payment of CHF 2 million in the event a call | put-option for the remaining 24% of Komax Malaysia is exercised.

Homburger advised I.M.A. with respect to Swiss law. The Homburger team was led by partner Dieter Gericke (Corporate | M&A) and included partner Stefan Oesterhelt (Tax), associates Eric Sibbern and Rafael Zemp and junior associate Nicolas Jauslin (all Corporate | M&A).